Rasa Griniūtė

Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia

William G. Wierda, Thomas J. Kipps, Jan Dürig et al. · Blood · 2011 · 121 citations · Full text

Medicine, Hematology, Oncology +7

Ofatumumab Combined With Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Results From a Randomized, Multicenter, International, Two-Dose, Parallel-Group Phase II Trial

William G. Wierda, Thomas J. Kipps, Jan Dürig et al. · Clinical Lymphoma Myeloma & Leukemia · 2010 · 40 citations

Medicine, Immunology, Oncology +13

High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study

Andreas Petzer, Dominik Wolf‎, Dominic Fong et al. · Haematologica · 2010 · 31 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Ofatumumab Combined with Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL): Results From a Randomized, Multicenter, International, Two-Dose, Parallel Group, Phase II Trial.

William G. Wierda, Thomas J. Kipps, Jan Dürig et al. · Blood · 2009 · 24 citations

Medicine, Oncology, Pharmacology +14

Prognostic value of reticulocyte hemoglobin content to diagnose iron deficiency in 6–24-month-old children

Rosita Kiudelienė, Rasa Griniūtė, Liutauras Labanauskas · Medicina · 2008 · 19 citations · Full text

Medicine, Hematology, Pediatrics +15